Innate immunity and vascular complications in type II diabetic South-Asian immigrants

• Conditions: cardiovascular disease; diabetes; nephropathy; retinopathy; 10011082; 10047060; 10029149

• Registration Number: NL-OMON30311
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 169

Inclusion Criteria

diabetes type II

Exclusion Criteria

geen

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- prevalence / progression nephropathy<br /><br>- prevalence retinopathy<br /><br>- prevalence ischemic heart disease<br /><br>- prevalence peripheral vascular disease<br /><br>- prevalence cerebral vascular accidents<br /><br>- intima media thickness of the carotid artery<br /><br>- pulse wave velocity analysis</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>no</p><br>